Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Monteiro

Showing results (141-150 of 166) with videos related to

Pageof 17
Sort By:
Current Oncology (Toronto, Ont.)|December 24, 2025
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in <i>BRCA1</i>Joanne Kotsopoulos, Adriana I Apostol, Kelly Metcalfe, et al.
Blood|September 19, 2022
Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphomaMaria Gluud, Emil M H Pallesen, Terkild B Buus, et al.
Human Mutation|June 28, 2022
Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordomaBing Xia, Kajal Biswas, Tzeh K Foo, et al.
Journal of Medical Genetics|February 4, 2015
BRCA1 Circos: a visualisation resource for functional analysis of missense variantsAnkita Jhuraney, Aneliya Velkova, Randall C Johnson, et al.
American Journal of Human Genetics|August 14, 2024
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert PanelMichael T Parsons, Miguel de la Hoya, Marcy E Richardson, et al.
American Journal of Human Genetics|February 25, 2025
Identification of genes associated with testicular germ cell tumor susceptibility through a transcriptome-wide association studyEmilio Ugalde-Morales, Rona Wilf, John Pluta, et al.
JCO Precision Oncology|September 14, 2019
Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working GroupSarah M Nielsen, Diana M Eccles, Iris L Romero, et al.
NPJ Genomic Medicine|March 5, 2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual diseaseDhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss, et al.
British Journal of Cancer|January 20, 2017
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility lociSiddhartha P Kar, Emily Adler, Jonathan Tyrer, et al.
Cancer Medicine|April 20, 2019
Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American WomenDelores J Grant, Ani Manichaikul, Anthony J Alberg, et al.
Pageof 17

Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Current Oncology (Toronto, Ont.)|December 24, 2025
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in <i>BRCA1</i>Joanne Kotsopoulos, Adriana I Apostol, Kelly Metcalfe, et al.
Blood|September 19, 2022
Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphomaMaria Gluud, Emil M H Pallesen, Terkild B Buus, et al.
Human Mutation|June 28, 2022
Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordomaBing Xia, Kajal Biswas, Tzeh K Foo, et al.
Journal of Medical Genetics|February 4, 2015
BRCA1 Circos: a visualisation resource for functional analysis of missense variantsAnkita Jhuraney, Aneliya Velkova, Randall C Johnson, et al.
American Journal of Human Genetics|August 14, 2024
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert PanelMichael T Parsons, Miguel de la Hoya, Marcy E Richardson, et al.
American Journal of Human Genetics|February 25, 2025
Identification of genes associated with testicular germ cell tumor susceptibility through a transcriptome-wide association studyEmilio Ugalde-Morales, Rona Wilf, John Pluta, et al.
JCO Precision Oncology|September 14, 2019
Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working GroupSarah M Nielsen, Diana M Eccles, Iris L Romero, et al.
NPJ Genomic Medicine|March 5, 2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual diseaseDhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss, et al.
British Journal of Cancer|January 20, 2017
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility lociSiddhartha P Kar, Emily Adler, Jonathan Tyrer, et al.
Cancer Medicine|April 20, 2019
Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American WomenDelores J Grant, Ani Manichaikul, Anthony J Alberg, et al.
Pageof 17